Legal
Key facts
A securities class action has been filed involving Regeneron Pharmaceuticals
Key facts
The matter concerns Regeneron Pharmaceuticals, Inc. and its stock ticker NASDAQ: REGN
Key facts
The alleged issue involves a Phase 3 clinical trial of a therapy intended to treat melanoma…
Atlas Watchline
Hagens Berman says investors can seek to lead a securities class action against Regeneron Pharmaceuticals after…